Literature DB >> 29893614

Bowel Perforation Resulting in Necrotizing Soft-Tissue Infection of the Abdomen, Flank, and Lower Extremities.

Disha Kumar1, Nicolás W Cortés-Penfield2, Hanine El-Haddad2,3, Daniel M Musher2,4.   

Abstract

BACKGROUND: Fournier's gangrene is a necrotizing soft-tissue infection (NSTI) that often originates from a break in bowel integrity and affects the perineum, anus, or genitalia. Although the pathogenesis is similar, NSTI caused by a break in bowel integrity less commonly presents as infection of other sites.
OBJECTIVE: To characterize NSTIs originating from bowel perforation and presenting as infection of the abdominal wall, flank, or thigh but that largely spare the perineum, anus, and genitalia.
METHODS: We describe a characteristic case and summarize findings from 67 reported cases.
RESULTS: The causes of bowel injury included trauma (29%), perforated appendicitis (23%), perforated diverticulitis (16%), and perforation of a gastrointestinal tract cancer (16%). The symptomatic prodrome is indolent and nondescript. Most patients have polymicrobial infections and require antibiotic therapy combined with serial surgical debridements. Because the presentation differs from that of typical Fournier's gangrene, recognition of NSTI was delayed in the reported cases, and the associated bowel perforation often was overlooked, leading to delayed surgical treatment. As a result, the mortality rate was >33%, far exceeding that of typical Fournier's gangrene. Delays in diagnosis or surgical intervention predict a poor outcome.
CONCLUSIONS: An NSTI resulting from bowel perforation can present in an atypical fashion carrying significant morbidity and mortality rates. Delayed diagnosis and treatment of this condition is associated with a poor outcome.

Entities:  

Keywords:  Fournier's gangrene; bowel injury; bowel perforation; necrotizing fasciitis; necrotizing soft-tissue infection

Mesh:

Substances:

Year:  2018        PMID: 29893614      PMCID: PMC6025700          DOI: 10.1089/sur.2018.022

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  24 in total

Review 1.  Necrotizing soft-tissue infections.

Authors:  R A Fontes; C M Ogilvie; T Miclau
Journal:  J Am Acad Orthop Surg       Date:  2000 May-Jun       Impact factor: 3.020

2.  Skin and soft tissue infection: necrotizing fasciitis.

Authors:  D E Low; A McGeer
Journal:  Curr Opin Infect Dis       Date:  1998-04       Impact factor: 4.915

Review 3.  Necrotizing soft-tissue infections.

Authors:  Jeffrey S Ustin; Mark A Malangoni
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

Review 4.  Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.

Authors:  D Hompes; T Ruers
Journal:  Eur J Surg Oncol       Date:  2011-07-20       Impact factor: 4.424

Review 5.  Necrotizing soft tissue infections.

Authors:  J D Urschel
Journal:  Postgrad Med J       Date:  1999-11       Impact factor: 2.401

Review 6.  Fournier's gangrene: a review of 1726 cases.

Authors:  N Eke
Journal:  Br J Surg       Date:  2000-06       Impact factor: 6.939

Review 7.  Necrotizing fasciitis: classification, diagnosis, and management.

Authors:  Luca Lancerotto; Ilaria Tocco; Roberto Salmaso; Vincenzo Vindigni; Franco Bassetto
Journal:  J Trauma Acute Care Surg       Date:  2012-03       Impact factor: 3.313

8.  The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections.

Authors:  Chin-Ho Wong; Lay-Wai Khin; Kien-Seng Heng; Kok-Chai Tan; Cheng-Ooi Low
Journal:  Crit Care Med       Date:  2004-07       Impact factor: 7.598

9.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

10.  Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

Authors:  M Smith; D Arthur; B Camitta; A J Carroll; W Crist; P Gaynon; R Gelber; N Heerema; E L Korn; M Link; S Murphy; C H Pui; J Pullen; G Reamon; S E Sallan; H Sather; J Shuster; R Simon; M Trigg; D Tubergen; F Uckun; R Ungerleider
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.